“Cytarabine (0.01-0.05 μM) showed a dose-dependent antiproliferative effect on AML cells, and in contrast … reached statistical significance even at 0.01 μM.ConclusionsEven low levels of cytarabine, and especially when combined with ATRA … valproic acid , can decrease T cell viability, … and decrease the cytokine release.”